{"DataElement":{"publicId":"13752222","version":"1","preferredName":"Modified Toxicity Criteria Insomnia Condition Grade","preferredDefinition":"A description of the modified toxicity criteria for insomnia grade.","longName":"13752155v1.00:13752171v1.00","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"13752155","version":"1","preferredName":"National Marrow Donor Program Modified Toxicity Criteria Insomnia Condition","preferredDefinition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain.:A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep._A state of being, such as a state of health.","longName":"13751560v1.00:13752154v1.00","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"13751560","version":"1","preferredName":"National Marrow Donor Program Modified Toxicity Criteria","preferredDefinition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain.","longName":"C199478","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Marrow Donor Program Modified Toxicity Criteria","conceptCode":"C199478","definition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCED37C0-8F10-1878-E053-731AD00AD0C4","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13752154","version":"1","preferredName":"Insomnia Condition","preferredDefinition":"A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep._A state of being, such as a state of health.","longName":"C28286:C25457","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Insomnia","conceptCode":"C28286","definition":"A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Condition","conceptCode":"C25457","definition":"A state of being, such as a state of health.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEE1FEB-E69C-3D35-E053-731AD00AB88B","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEE1FEB-E69D-3D35-E053-731AD00AB88B","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"2023.7.6 Released per review. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13752171","version":"1","preferredName":"National Marrow Donor Program Modified Toxicity Criteria Insomnia Grade","preferredDefinition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain._A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep._A position on a scale of intensity or amount or quality.","longName":"13752171v1.00","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"120","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Normal","valueDescription":null,"ValueMeaning":{"publicId":"13752201","version":"1","preferredName":"Normal","longName":"13752201v1.00","preferredDefinition":"Normal (grade 0)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEF7202-8315-7A07-E053-731AD00AAE5E","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCEF7202-8318-7A07-E053-731AD00AAE5E","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"},{"value":"Occasional difficulty sleeping, not interfering with function","valueDescription":null,"ValueMeaning":{"publicId":"13752202","version":"1","preferredName":"Occasional difficulty sleeping, not interfering with function","longName":"13752202v1.00","preferredDefinition":"Occasional difficulty sleeping, not interfering with function (grade 1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEF7202-8316-7A07-E053-731AD00AAE5E","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCEF7202-8319-7A07-E053-731AD00AAE5E","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"},{"value":"Disabling","valueDescription":null,"ValueMeaning":{"publicId":"13752203","version":"1","preferredName":"Disabling","longName":"13752203v1.00","preferredDefinition":"Disabling (grade 4)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEF7202-8317-7A07-E053-731AD00AAE5E","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCEF7202-831C-7A07-E053-731AD00AAE5E","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"},{"value":"Difficulty sleeping, interfering with function but not interfering with ADL","valueDescription":null,"ValueMeaning":{"publicId":"13752204","version":"1","preferredName":"Difficulty sleeping, interfering with function but not interfering with ADL","longName":"13752204v1.00","preferredDefinition":"Difficulty sleeping, interfering with function but not interfering with ADL (grade 2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEF791F-C22D-7AF6-E053-731AD00A9DBA","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCEF791F-C22F-7AF6-E053-731AD00A9DBA","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"},{"value":"Frequent difficulty sleeping, interfering with ADL","valueDescription":null,"ValueMeaning":{"publicId":"13752205","version":"1","preferredName":"Frequent difficulty sleeping, interfering with ADL","longName":"13752205v1.00","preferredDefinition":"Frequent difficulty sleeping, interfering with ADL (grade 3)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEF791F-C22E-7AF6-E053-731AD00A9DBA","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FCEF791F-C230-7AF6-E053-731AD00A9DBA","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13752170","version":"1","preferredName":"National Marrow Donor Program Modified Toxicity Criteria Insomnia Grade","preferredDefinition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain._A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep._A position on a scale of intensity or amount or quality.","longName":"13752170v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"National Marrow Donor Program Modified Toxicity Criteria","conceptCode":"C199478","definition":"Criteria established by the National Marrow Donor Program (NMDP) that assesses potential toxicities following peripheral blood or bone marrow stem cell collection from donors and includes: fever in absence of infections; fatigue; rashes; injection site reaction; nausea; vomiting; loss of appetite; inability to sleep; dizziness, vertigo, or lightheadedness; fainting; and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Insomnia","conceptCode":"C28286","definition":"A sleep disorder characterized by difficulty in falling asleep and/or remaining asleep.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEE96C4-4DBE-56B3-E053-731AD00A30D6","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCEE96C4-4DBF-56B3-E053-731AD00A30D6","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"2023.7.6 Released per review. ak2023.5.30 Created per ticket request CADSR0002455. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the modified toxicity criteria for insomnia grade?","url":null,"context":"NHLBI"},{"name":"NMDP Text 1","type":"Alternate Question Text","description":"Inability to sleep (insomnia)","url":null,"context":"NHLBI"},{"name":"NMDP Text 2","type":"Application Standard Question Text","description":"Inability to sleep","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF00FDB-6C65-13D0-E053-731AD00A6CAE","latestVersionIndicator":"Yes","beginDate":"2023-05-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-05-30","modifiedBy":"KUMMEROA","dateModified":"2023-07-06","changeDescription":null,"administrativeNotes":"2023.7.6 Released per review. ak","unresolvedIssues":null,"deletedIndicator":"No"}}